Transatlantic Cancer Collaboration Seeks to Accelerate Early Detection
December 15, 2015.
Cancer Research UK has formed an international collaboration with the Knight Cancer Institute at Oregon Health & Science University (OHSU) to accelerate research in the early detection of cancer.
The collaboration also seeks to accelerate progress by identifying and tackling the barriers scientists, including:
• A lack of research models for the earliest stages of the disease
• A shortage of tissue samples available for research, especially samples from higher risk patients
• Limited funding for this type of research
• The need for a better understanding of the biology of early cancer and appropriate technologies to detect its features.
In June 2015 the OHSU Knight Cancer Institute announced that it had raised $1 billion to support its vision to realize the full potential of precision cancer medicine. The funds enabled the institute to begin fast-track recruitment of top researchers to join its team and accelerate construction of a research building and cancer clinic space to support its expansion.
The Cancer Research-OHSU collaboration will host an annual international conference series beginning in 2016.
Is Artificial Intelligence a ‘Product’? Products Liability Implications for AI-Based Products
April 10th 2025As the physical products we use evolve to become increasingly complex, traditional products liability frameworks may not always fit to provide remedies for harm that can result from using novel product types.
